A recent study highlights a surprising potential benefit of diabetes and obesity drugs, GLP-1 receptor agonists, in improving ...

GLP-1 weight-loss drugs are in the news because so many people are using them to treat obesity and diabetes. With so many ...

This randomized controlled trial shows that structured moderate-to-vigorous exercise, alone or combined with liraglutide, ...

GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that the first participants have been dosed in a U.S. 13-week ...

Most patients receiving a GLP-1 receptor agonist (RA) and a biologic continue co-therapy for over a year with few treatment-related adverse events.

The actress opened up to PEOPLE about her “miraculous” weight loss ...

Drugs like Ozempic already have a big impact on how much patients eat - and now they may be changing the way they shop and ...

Approval clears the regulatory path for a lower-cost GLP-1 weight-loss drug in India, but commercial launch hinges on semaglutide patent expiry.

The GLP-1 tirzepatide is only one half of the puzzle.

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide. Epidemiological evidence indicates that MASLD is associated with an ...

A new analysis of research into the most common type of breast cancer has zeroed in on an overlooked hormone that may be ...